tirzepatide arthritis A Study to Investigate Effectiveness of Following Initiation of Ixekizumab in Participants With Active Psoriatic and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) GLP-1 Agonist plus IL-17 Inhibition
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



















